Received: 9 May 2019
Accepted: 12 June 2020
First Online: 19 June 2020
Ethics approval and consent to participate
: This study was approved by the Institutional Review Board of CHOC Children’s Hospital (180857) and deemed “Exempt from review” due to the use of fully deidentified data. As a result, informed consent was waived by the IRB.
: Not applicable.
: Gary Gasperino is employed by and promote the use of HealtheDataLab for Cerner Corporation and as a result has competing interest. However, evaluation of the platform and the three use cases presented here were carried out independently by the CHOC Children’s Hospital. The decision to publish was made independently by the corresponding author’s institution.